deionized water using Sodium Hydroxide, Anhydrous, Sigma Stock
No. 505-8. Standardize according to the ACS Reagent Procedure.1)
F. 5 mM Calcium Chloride Solution
(Prepare 25 ml in deionized water using
deionized water using Sodium Hydroxide, Anhydrous, Sigma Stock
No. 505-8. Standardize according to the ACS Reagent Procedure.1)
F. 5 mM Calcium Chloride Solution
(Prepare 25 ml in deionized water using
deionized water using Sodium Hydroxide, Anhydrous, Sigma Stock
No. 505-8. Standardize according to the ACS Reagent Procedure.1)
F. 5 mM Calcium Chloride Solution
(Prepare 25 ml in deionized water using
deionized water using Sodium Hydroxide, Anhydrous, Sigma Stock
No. 505-8. Standardize according to the ACS Reagent Procedure.1)
F. 5 mM Calcium Chloride Solution
(Prepare 25 ml in deionized water using
deionized water using Sodium Hydroxide, Anhydrous, Sigma Stock
No. 505-8. Standardize according to the ACS Reagent Procedure.1)
F. 5 mM Calcium Chloride Solution
(Prepare 25 ml in deionized water using
deionized water using Sodium Hydroxide, Anhydrous, Sigma Stock
No. 505-8. Standardize according to the ACS Reagent Procedure.1)
F. 5 mM Calcium Chloride Solution
(Prepare 25 ml in deionized water using
deionized water using Sodium Hydroxide, Anhydrous, Sigma Stock
No. 505-8. Standardize according to the ACS Reagent Procedure.1)
F. 5 mM Calcium Chloride Solution
(Prepare 25 ml in deionized water using
caspase-3 substrate . (Ex at 400 nm
and Em at 505 nm) can be measured
using a fluorometer or a fluorescence
microplate reader .
1 Kit €803
Caspase-5
Assay Kit,
Colorimetric
218804 Colorimetric
caspase-3 substrate . (Ex at 400 nm
and Em at 505 nm) can be measured
using a fluorometer or a fluorescence
microplate reader .
1 Kit
Caspase-5
Assay Kit,
Colorimetric
218804 Colorimetric
-phospho-PKCι (Thr555)/PKCλ (Thr563) H M WB APur Rb IgG 100 µL 07-881
PKC ι, active KA 10 µg 14-505
PKCμ
Antibody
Anti-phospho-PKCµ/PKD (Ser742) H M WB APur Rb IgG 100 µL 07-882
PKCµ, active
006149.2 y n/d y
497 Neurofibromin N3662 4763 NF1 M NP_000258.1,NP_001035957.1 ,NP_001121619.1 y y y
505 NF-kB N8523 4790 NFKB1 M NP_001158884.1 y y n/d
378 IkBa I0505 4792 NFKBIA P NP_065390.1 y y y
491
006149.2 y n/d y
497 Neurofibromin N3662 4763 NF1 M NP_000258.1,NP_001035957.1 ,NP_001121619.1 y y y
505 NF-kB N8523 4790 NFKB1 M NP_001158884.1 y y n/d
378 IkBa I0505 4792 NFKBIA P NP_065390.1 y y y
491
006149.2 y n/d y
497 Neurofibromin N3662 4763 NF1 M NP_000258.1,NP_001035957.1 ,NP_001121619.1 y y y
505 NF-kB N8523 4790 NFKB1 M NP_001158884.1 y y n/d
378 IkBa I0505 4792 NFKBIA P NP_065390.1 y y y
491
anti-phospho-PKCι (Thr555)/PKCλ (Thr563) H M WB APur Rb IgG 100 µL 07-881
Protein
PKCι, active KA 10 µg 14-505
PKCµ
Polyclonal Antibody
Anti-phospho-PKCµ/PKD (Ser742) H M WB APur Rb IgG 100 µL 07-882
Neurofilament 68 N5139 M y n/d n/d
503 Neurofilament 160/200 N2912 M y y y
504 Anti Cy3+Cy5 C0992 M NA NA NA
505 NF-κB N8523 M y y n/d
506 NAK (NFκB-Activating Kinase) N2661 M y n/d y
507 NG2 N8912 M n/d n/d
N5139 4747 NEFL NP_006149.2 M y n/d n/d
503 Neurofilament 160/200 N2912 M y y y
504 Anti Cy3+Cy5 C0992
505 NF-κB N8523 18033, 4790 NFKB1,Nfkb1 NP_032715.2,NP_003989.2 M y y n/d
506 NAK (NFκB-Activating Kinase
200 nM or 3.8 µM using pNPP or phosphorylated Ick
505 peptide as a substrate,
respectively). Does not effectively inhibit PTPIB (IC50 Ick
505 peptide as a substrate).
The phenanthrenedione group